Curaleaf's QMID Enters Australia Class IIb Register

Curaleaf International Secures Australian First with TGA Registered Liquid Medical Cannabis Inhalation Device and Extends Availability to New Zealand

LONDON, Oct. 2, 2026 /PRNewswire/ -- Curaleaf International, part of Curaleaf Holdings, Inc. (TSX:CURA) in partnership with Jupiter Research LLC, today announced that its Que...

Curaleaf’s Liquid Medical Marijuana Inhaler Becomes First of Its Kind Registered in Australia

The Marijuana Herald - Marijuana news and information Curaleaf International says its liquid medical marijuana inhalation device has become the first of its kind to receive regulatory approval in Australia, following its inclusion … Continue reading

Curaleaf's QMID enters Australia Class IIb register

Curaleaf ties QMID to Australian Class IIb ARTG entry 531287 dated Sept. 15 and reports a New Zealand WAND notification on Sept. 17.

Curaleaf Holdings' QMID enters Australia's Class IIb medical device register

Australia's Therapeutic Goods Administration added an ambulatory therapeutic agent vaporizer to its medical device register on Sept. 15, classifying it as Class IIb. Curaleaf Holdings, Inc. (TSE: CURA) (OTCMKTS: CURLF) identified the device on Oct. 2 as its Que Medical Inhalation Device, or QMID, and said it is now available in seven countries. Curaleaf shares closed at C$14.66 in Toronto at 4 p.m. EDT on Oct. 1, according to the TSE: CURA quote…